Parkinson?s Treatment Market

Posted by ahila on April 27th, 2018

Global Parkinson’s Treatment Market :Parkinson’s disease is the chronic, progressive neurodegenerative disorder that is characterized by rigidity, tremors, postural instability and bradykinesia (slowness of movement) and patients will also experience the significant non-motor symptoms like changes in the sleep disturbances, autonomic dysfunction and cognition and mood. The condition is caused due to the degeneration of the dopamine-producing cells of substantia nigra. Parkinson’s disease is non-fatal but it cannot be cured, that results in the poor quality of life and increases disability along with the disease progression. As per the World Health Organization, the total number of people with disability-adjusted life year because of Parkinson’s disease was 1.7 Mn globally in 2015.

Recent advancements in the treatment of  Parkinson’s disease like combination or multiple  therapies in order to prolong the actions of the continuous stimulation of dopaminergic drugs, neurostimulation devices approvals, neuroprotective therapies which slows the prognosis of Parkinson’s disease are anticipated to drive Parkinson’s disease treatment market globally.Furthermore, increase in aging of the population, rise in the Parkinsonism prevalence around the globe, treatment affordability are the factors bolstering the demand for some of the Parkinson’s disease treatment market. Factors such as loss of patent protection for some of the drugs, rise in competition from generic drugs of Parkinsonism, huge unmet needs in the market, delaying development and launch of new products in market are the few restraints for the Parkinson’s disease treatment market growth. High competition in market from other improved Parkinson’s disease management methods also hinders the growth of the Parkinson’s treatment market.

     A sample of this report is available upon request @

The global Parkinson’s treatment market has been classified on the basis of treatment, end user, and geography.

Based on drug class, global Parkinson’s treatment market is segmented into the following:

  • Monoamine Oxidase Inhibitors (MAO)
  • Dopamine Precursors
  • Catechol-o-methyltransferase Inhibitors (COMT)
  • Peripheral Decarboxylase Inhibitors
  • Others (Anticholinergics, Antihistaminics)

Based on distribution channel, global Parkinson’s treatment market segmented as:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Drug Stores

  To view TOC of this report is available upon request @

Like it? Share it!


About the Author

Joined: March 20th, 2018
Articles Posted: 168

More by this author